Article

Mendelian randomization analysis identifies blood tyrosine levels as a biomarker of non-alcoholic fatty liver disease

2021-11-28

Abstract excerpt

Non-alcoholic fatty liver disease (NAFLD) is a complex cardiometabolic disease associated with premature mortality. The diagnosis of NAFLD is challenging and the identification of biomarkers causally influenced by NAFLD may be clinically useful. We aimed at identifying blood metabolites causally impacted by NAFLD using two-sample Mendelian randomization (MR) with validation in a population-based biobank and a coho...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: a26f4d2d-bc7f-55c6-83f8-1e152b4d2ee0
DOI: 10.1101/2021.11.26.21266879

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Mendelian randomization analysis identifies blood tyrosine levels as a biomarker of non-alcoholic fatty liver diseaseDOI 10.1101/2021.11.26.21266879Read

Mendelian Randomization Analysis Identifies Blood Tyrosine Levels as a Biomarker of Non-Alcoholic Fatty Liver DiseaseSemantic proximity Read

Electronic Health Record-Based Genome-Wide Meta-Analysis and Mendelian Randomization Identify Metabolic and Phenotypic Consequences of Non-Alcoholic Fatty Liver DiseaseSemantic proximity Read

NAFLD’s Predisposion: insight from phenome-wide association and Mendelian RandomizationSemantic proximity Read

Association between leptin and NAFLD: A Two-Sample Mendelian randomization studySemantic proximity Read

Causal relationships between genetically predicted circulating levels of amino acids and non-alcoholic fatty liver disease risk: a Mendelian randomisation studySemantic proximity Read

A Multivariable Mendelian Randomization Analysis Disentangling The Causal Relations Between Abdominal Obesity, Non-Alcoholic Fatty Liver Disease and Cardiometabolic DiseasesSemantic proximity Read

Evaluating the role of non-alcoholic fatty liver disease in cardiovascular diseases and type 2 diabetes: a Mendelian randomization study in Europeans and East Asians.Semantic proximity Read

Unveiling Promising Drug Targets for NAFLD through Mendelian RandomizationSemantic proximity Read

Mendelian Randomization Analysis Dissects the Relationship between NAFLD, T2D, and Obesity and Provides Implications to Precision MedicineSemantic proximity Read

The associations between modifiable risk factors and nonalcoholic fatty liver disease: A comprehensive Mendelian randomization studySemantic proximity Read

Role of plasma metabolome in mediating the effect of plasma lipidome on NAFLD: a Mendelian randomization studySemantic proximity Read

Nonalcoholic fatty liver disease and type 2 diabetes: an observational and Mendelian randomization studySemantic proximity Read